BUENA, N.J., Oct. 29, 2013 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced its financial results for the third quarter ended September 30, 2013.
Third Quarter and Year to Date 2013 Highlights
-- Total revenues of $4.0 million in the third quarter of 2013, an increase of 100% over the same quarter in 2012
Help employers find you! Check out all the jobs and post your resume.
